Cîrjaliu, R.-E.; Tofolean, I.-T.; Tofolean, D.-E.; Chisoi, A.; Oancea, C.; Vastag, E.; Marc, M.; Bratosin, F.; Rosca, O.; Fildan, A.-P.
Predictive Value and Diagnostic Potential of IL-10, IL-17A, IL1-β, IL-6, CXCL, and MCP for Severe COVID-19 and COVID-19 Mortality. Biomedicines 2024, 12, 1532.
https://doi.org/10.3390/biomedicines12071532
AMA Style
Cîrjaliu R-E, Tofolean I-T, Tofolean D-E, Chisoi A, Oancea C, Vastag E, Marc M, Bratosin F, Rosca O, Fildan A-P.
Predictive Value and Diagnostic Potential of IL-10, IL-17A, IL1-β, IL-6, CXCL, and MCP for Severe COVID-19 and COVID-19 Mortality. Biomedicines. 2024; 12(7):1532.
https://doi.org/10.3390/biomedicines12071532
Chicago/Turabian Style
Cîrjaliu, Roxana-Elena, Ioan-Tiberiu Tofolean, Doina-Ecaterina Tofolean, Anca Chisoi, Cristian Oancea, Emanuela Vastag, Monica Marc, Felix Bratosin, Ovidiu Rosca, and Ariadna-Petronela Fildan.
2024. "Predictive Value and Diagnostic Potential of IL-10, IL-17A, IL1-β, IL-6, CXCL, and MCP for Severe COVID-19 and COVID-19 Mortality" Biomedicines 12, no. 7: 1532.
https://doi.org/10.3390/biomedicines12071532
APA Style
Cîrjaliu, R.-E., Tofolean, I.-T., Tofolean, D.-E., Chisoi, A., Oancea, C., Vastag, E., Marc, M., Bratosin, F., Rosca, O., & Fildan, A.-P.
(2024). Predictive Value and Diagnostic Potential of IL-10, IL-17A, IL1-β, IL-6, CXCL, and MCP for Severe COVID-19 and COVID-19 Mortality. Biomedicines, 12(7), 1532.
https://doi.org/10.3390/biomedicines12071532
